REVVITY SIGNALS SOFTWARE, INC.

Revvity Signals Software’s advanced analytics and services solutions for Clinical Development help the world’s leading biopharmaceutical, medical device, and diagnostics manufactures discover new therapeutics faster through their clinical data review, medical monitoring, and medical review capabilities; streamlining clinical operations, transforming risk into safety and enabling actionable decisions that can lead to better health outcomes.

FEATURED PRODUCTS

Watch to learn about an end-to-end clinical data science platform designed to streamline the rapid generation of deep insights from clinical trial data, enabling efficient delivery of crucial analyses.

WEBINARS

Discover how streamlined workflows and enhanced collaboration between data managers and medical reviewers can boost clinical trial efficiency, improve data quality, and ensure patient safety.

AI has great potential to enhance the efforts of your team members by accelerating data interactions. Watch this webinar and discover how AI can improve clinical trial outcomes and data management.

Discover how embracing fast and flexible clinical analytics can help you address clinical questions and provide real-time insights into data issues as they arise.

Explore key challenges in accessing and preparing analytics-ready clinical data, how FAIR guiding principles can help maximize the value of clinical trial data, and the impact of innovative analytics.

CONTACT INFORMATION

Revvity Signals Software, Inc.

77 4th Ave

Waltham, MA 02451

UNITED STATES

Phone: 203 925-4602

FEATURED ARTICLES

  • Building an "analytics culture" in clinical research requires striking a balance between fast, flexible technologies and the right support for trial teams working to integrate these solutions.

  • Prioritize data management that adheres to FAIR principles — findable, accessible, interoperable, and reusable — to gain operational insights that enable quick decisions and ensure participant well-being.

  • Read on as authors explore accessing real-time clinical trial data for proactive study management, using adverse event data to enhance safety and performance, and tools to improve design.

  • Learn how to create a system based on connectivity and automation, aggregated and usable data, flexible analysis, and methods of collaborative data review by centralizing analysis and communications.

  • To achieve drug approval, trials must collect, combine, and analyze diverse data sets that support operational, safety review, risk management, and other analyses crucial to development.

  • In a recent webinar, experts from Revvity Signals Software explored how solutions like its Spotfire platform enable better, more streamlined clinical studies.

  • Discover how a single, integrated data analytics and visualization platform, supported by an experienced partner, can help you move your investigational product to market more quickly.

  • Reasoning for physician monitors’ reluctance, and what technology needs to offer to convince monitors their work can be more efficient: quickly detecting safety signals and speeding time to submission.

  • To enable the completion of clinical trials as safely, efficiently, and quickly as possible, Revvity Signals Software’s clinical solutions streamline trial data visualization and analysis with real-time access to data in all phases of development.

  • How to identify, hire, and empower a modern medical monitor to help your next study proceed toward submission more productively, and with greater data integrity, than ever before.

  • In this interview, Jennifer Prichard, MD, Medical Monitor at Atlantic Research Group, and Hunter Walker, CTO at Atlantic Research Group (a CRO) will discuss challenges with existing medical monitoring processes, and how new technologies can help improve efficiency.

  • The adoption of RBM is increasing as companies provide greater management support, staff training and more sophisticated technology systems. Technology platforms that enable continuous monitoring with near real-time intuitive visualizations, analytic dashboards and applications will allow issues to be identified and addressed early, improving study safety and efficiency.

  • This article discusses ways to adopt patient-centered drug development, changing the corporate culture and trial design, understanding patient needs and incorporating them into trials, and leveraging technology to conduct remote patient-centric clinical trials.

  • Explore data challenges faced by sponsors, the underlying problems driving those challenges, and flexible processes and solutions designed to help overcome them.

  • Look at some of the main challenges of clinical data review and effective strategies to address these, as well as solutions that can be deployed to bring urgently needed therapeutics to patients faster.